In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...

Bayer's agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, claiming that they used its patent-protected technology in their products.

A Covid vaccine researcher claims she was silenced for years right before warning the public about the dangers to certain ...

The only man in his immediate family to be without a cancer diagnosis, one Lynch syndrome patient made the trip to ...

The recombinant, protein-based vaccine is one of only a handful of acne vaccines worldwide promising alternative treatment.

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...

UK MHRA approves zapomeran mRNA Covid-19 vaccine for immunisation of individuals aged 18 years of age and older: United Kingdom Monday, January 5, 2026, 11:00 Hrs [IST] The Medici ...

Sanofi's acquisition of Dynavax, valued at $2.2 billion, aims to enhance its vaccine portfolio, including a promising shingles vaccine candidate, Z-1018. Z-1018 has demonstrated comparable ...

The experimental mRNA-based drug sharply reduced the risk of recurrence or death when combined with immunotherapy Keytruda, ...

Think you're immune to misinformation? Time for a fact booster.

In a major boost for health research, 22 UQ researchers and teams have secured $29 million from the National Health and ...